Endosomal egress and intercellular transmission of hepatic ApoE-containing lipoproteins and its exploitation by the hepatitis C virus

PLoS Pathog. 2023 Jul 28;19(7):e1011052. doi: 10.1371/journal.ppat.1011052. eCollection 2023 Jul.

Abstract

Liver-generated plasma Apolipoprotein E (ApoE)-containing lipoproteins (LPs) (ApoE-LPs) play central roles in lipid transport and metabolism. Perturbations of ApoE can result in several metabolic disorders and ApoE genotypes have been associated with multiple diseases. ApoE is synthesized at the endoplasmic reticulum and transported to the Golgi apparatus for LP assembly; however, the ApoE-LPs transport pathway from there to the plasma membrane is largely unknown. Here, we established an integrative imaging approach based on a fully functional fluorescently tagged ApoE. We found that newly synthesized ApoE-LPs accumulate in CD63-positive endosomes of hepatocytes. In addition, we observed the co-egress of ApoE-LPs and CD63-positive intraluminal vesicles (ILVs), which are precursors of extracellular vesicles (EVs), along the late endosomal trafficking route in a microtubule-dependent manner. A fraction of ApoE-LPs associated with CD63-positive EVs appears to be co-transmitted from cell to cell. Given the important role of ApoE in viral infections, we employed as well-studied model the hepatitis C virus (HCV) and found that the viral replicase component nonstructural protein 5A (NS5A) is enriched in ApoE-containing ILVs. Interaction between NS5A and ApoE is required for the efficient release of ILVs containing HCV RNA. These vesicles are transported along the endosomal ApoE egress pathway. Taken together, our data argue for endosomal egress and transmission of hepatic ApoE-LPs, a pathway that is hijacked by HCV. Given the more general role of EV-mediated cell-to-cell communication, these insights provide new starting points for research into the pathophysiology of ApoE-related metabolic and infection-related disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apolipoproteins E / metabolism
  • Endosomes / metabolism
  • Hepacivirus* / physiology
  • Hepatitis C*
  • Humans
  • Lipopolysaccharides / metabolism
  • Virus Assembly / physiology

Substances

  • Lipopolysaccharides
  • Apolipoproteins E

Grants and funding

This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 272983813 – TRR 179 to RB and Project Number 240245660 - SFB1129 to RB and KR. The work was also supported by the German Center for Infection Research (DZIF), project number TTU 05.821 to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.